Please use this identifier to cite or link to this item:
https://ahro.austin.org.au/austinjspui/handle/1/26176| Title: | SPON1 Is Associated with Amyloid-β and APOE ε4-Related Cognitive Decline in Cognitively Normal Adults. | Austin Authors: | Fernandez, Shane;Burnham, Samantha C;Milicic, Lidija;Savage, Greg;Maruff, Paul;Peretti, Madeline;Sohrabi, Hamid R;Lim, Yen Ying;Weinborn, Michael;Ames, David;Masters, Colin L ;Martins, Ralph N;Rainey-Smith, Stephanie;Rowe, Christopher C ;Salvado, Olivier;Groth, David;Verdile, Giuseppe;Villemagne, Victor L ;Porter, Tenielle;Laws, Simon M | Affiliation: | School of Psychological Science, University of Western Australia, Crawley, Western Australia, Australia National Ageing Research Institute, Parkville, Victoria, Australia Centre for Healthy Ageing, Murdoch University, Murdoch, Western Australia, Australia ARC Centre of Excellence in Cognition and its Disorders, Department of Psychology, Macquarie University, North Ryde, NSW, Australia Australian Alzheimer's Research Foundation, Nedlands, Western Australia Collaborative Genomics and Translation Group, Center for Precision Health, School of Medical and Health Sciences, Edith Cowan University, Joondalup, Western Australia, Australia Turner Institute for Brain and Mental Health, School of Psychological Sciences, Monash University, Clayton, Victoria, Australia The Florey Institute of Neuroscience and Mental Health, The University of Melbourne, Parkville, Victoria, Australia CogState Ltd., Melbourne, Victoria, Australia CSIRO Health and Biosecurity, Parkville, Victoria, Australia Molecular Imaging and Therapy Centre of Excellence for Alzheimer's Disease Research and Care, School of Medical and Health Sciences, Edith Cowan University, Joondalup, Western Australia, Australia School of Pharmacy and Biomedical Sciences, Faculty of Health Sciences, Curtin Health Innovation Research Institute, Curtin University, Bentley, Western Australia, Australia Department of Biomedical Sciences, Faculty of Medicine and Health Sciences, Macquarie University, Sydney, New South Wales, Australia CSIRO Health and Biosecurity/Australian e-Health Research Centre, Herston, Queensland, Australia Medicine (University of Melbourne) Academic Unit for Psychiatry of Old Age, St. Vincent's Health, The University of Melbourne, Kew, Victoria, Australia |
Issue Date: | 24-Feb-2021 | Date: | 2021-02-24 | Publication information: | Journal of Alzheimer's Disease Reports 2021; 5(1): 111-120 | Abstract: | Genetic variation in Spondin-1, specifically rs11023139, has been associated with reduced rates of cognitive decline in individuals with Alzheimer's disease. The aim of this study was to assess whether the association was present in cognitively normal older adults. Longitudinal cognitive decline was investigated using linear mixed modelling in a cohort of 590 cognitively normal older adults enrolled in the Australian Imaging, Biomarkers and Lifestyle Study. No independent effect of Spondin-1 rs11023139 on cognitive decline was observed. However, significant associations were observed for the interaction between Apolipoprotein E (APOE)ɛ4 and rs11023139 in individuals with high amyloid-β burden. APOEɛ4/rs11023139-A carriers declined significantly faster than APOEɛ4/rs11023139-G_G carriers in measures of global cognition (p = 0.011) and verbal episodic memory (p = 0.020). These results suggest that carriage of the Spondin-1 rs11023139-A allele significantly contributes to a worsening of cognitive performance in APOEɛ4 cognitively normal older adults with a high neocortical amyloid-β burden. | URI: | https://ahro.austin.org.au/austinjspui/handle/1/26176 | DOI: | 10.3233/ADR-200246 | Journal: | Journal of Alzheimer's Disease Reports | PubMed URL: | 33782664 | Type: | Journal Article | Subjects: | APOE Alzheimer’s disease SPON1 Spondin-1 amyloid-β cognitive decline |
| Appears in Collections: | Journal articles |
Show full item record
Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.